MSA helps distinguish JDM from other connective tissue disorders, which is useful in diagnosis for patients with cutaneous features non-specific to dermatomyositis, while anti-MDA5 antibody is particularly important in patients presenting with skin ulcers of unknown etiology even without muscle weakness as the disease can be subtle on initial presentation. This evidence concerns the gene IFIH1 and juvenile dermatomyositis.